Page last updated: 2024-09-03

ly 255283 and resolvin e2

ly 255283 has been researched along with resolvin e2 in 1 studies

Compound Research Comparison

Studies
(ly 255283)
Trials
(ly 255283)
Recent Studies (post-2010)
(ly 255283)
Studies
(resolvin e2)
Trials
(resolvin e2)
Recent Studies (post-2010) (resolvin e2)
5401517112

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, H; Ikeda, H; Ishimura, K; Ono, Y; Sato, Y; Shuto, S; Tansho-Nagakawa, S; Ubagai, T; Unno, Y; Watanabe, M1

Other Studies

1 other study(ies) available for ly 255283 and resolvin e2

ArticleYear
Resolvin E1, but not resolvins E2 and E3, promotes fMLF-induced ROS generation in human neutrophils.
    FEBS letters, 2018, Volume: 592, Issue:16

    Topics: Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Humans; Inflammation; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; Onium Compounds; Reactive Oxygen Species; Receptors, Leukotriene B4; Tetrazoles

2018